Biotricity Inc. (BTCY): Revenue
$16.00M
Year ended 2026-03-31
$16.40M
Trailing 12 months to 2026-06-30
+18.4%
3-year compound annual growth
+36.4%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $16.00M | +16.0% | 2026-07-14, From 2025-04-01 |
| 2025-03-31 | $13.79M | +14.3% | 2026-07-14, From 2024-04-01 |
| 2024-03-31 | $12.06M | +25.2% | 2025-07-18, From 2023-04-01 |
| 2023-03-31 | $9.64M | +26.0% | 2024-06-27, From 2022-04-01 |
| 2022-03-31 | $7.65M | +126.0% | 2023-06-29, From 2021-04-01 |
| 2021-03-31 | $3.38M | +138.7% | 2022-07-14, From 2020-04-01 |
| 2020-03-31 | $1.42M | +256.0% | 2021-06-22, From 2019-04-01 |
| 2019-03-31 | $398.2K | n/a | 2020-07-15, From 2018-04-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Biotricity Inc. (BTCY) | 2026-03-31 | $16.00M | +16.0% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $16.10M | +50.7% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $15.23M | -52.6% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $17.44M | +16.0% |
| Nephros Inc (NEPH) | 2025-12-31 | $18.79M | +32.7% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $19.53M | +36.7% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $19.65M | -33.6% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $22.36M | -17.3% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $11.42M | +31.5% |
Compare BTCY, PROF, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗